Therapeutic Implications for MS

[Guest guest]

Recent paper being published from Dr Ian Zagon:- These results indicate that treatment with OGF or LDN had no deleterious long-term repercussions and did not exacerbate EAE, but i) halted progression of disease, ii) reversed neurological deficits, and iii) prevented the onset of neurological deficits and iii) prevented the onset of neurological dysfunction across a considerable span of time http://www.ncbi.nlm.nih.gov/pubmed/21256121 Jayne Crocker www.LDNNow.comImportant! Please sign our LDN petition to the European Parliament by clicking heretel: +44 (0) 7877 492 669Dr Steele MBE, talking about LDNLDNNow are a political/pressure group of individuals dedicated to getting Low Dose Naltrexone (LDN) accepted into modern medicine and trialled for the myriad of uses it shows benefit for. .

[Guest guest]

Sorry, someone just advised they couldn’t access the link, just seen my sent messages and it appears I forgot to post the link http://www.ncbi.nlm.nih.gov/pubmed/21256121 Recent paper being published from Dr Ian Zagon:- These results indicate that treatment with OGF or LDN had no deleterious long-term repercussions and did not exacerbate EAE, but i) halted progression of disease, ii) reversed neurological deficits, and iii) prevented the onset of neurological deficits and iii) prevented the onset of neurological dysfunction across a considerable span of time Jayne Crocker www.LDNNow.comImportant! Please sign our LDN petition to the European Parliament by clicking heretel: +44 (0) 7877 492 669Dr Steele MBE, talking about LDNLDNNow are a political/pressure group of individuals dedicated to getting Low Dose Naltrexone (LDN) accepted into modern medicine and trialled for the myriad of uses it shows benefit for. .